Home›Companies›Biotech & Pharma›Renova Therapeutics

Renova Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 9, 2024·Suggest an edit

About Renova Therapeutics

Renova Therapeutics is a private company based in Carlsbad, California. It has reported $166,500 raised in one offering on Form D since September 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2024Sep 9, 2024$166,500of $500K target7$23,786Equity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Renova Therapeutics's Form D filed Sep 9, 2024.

RC
Roy Cosan
Director
PL
VM
Vijay Mahant
Director
MT
KH
Kirk Hammond
Director
MX
Morgan Xu
Director
SS
Shawn Swaney
Chief Operating Officer

Sources

  1. SECRenova Therapeutics, Inc. filing history